FDA Approved: XOSPATA — Original Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved XOSPATA (gilteritinib) as an original application for adult patients with relapsed or refractory FLT3-mutated acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Xospata (gilteritinib)

Snippet

ORIG AP for XOSPATA (GILTERITINIB)